Tissue catabolism and donor-specific dexamethasone response in a human osteochondral model of post-traumatic osteoarthritis

BACKGROUND: Post-traumatic osteoarthritis (PTOA) does not currently have clinical prognostic biomarkers or disease-modifying drugs, though promising candidates such as dexamethasone (Dex) exist. Many challenges in studying and treating this disease stem from tissue interactions that complicate under...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Rebecca Mae, Flaman, Lisa L., Lindblom, Karin, Chubinskaya, Susan, Grodzinsky, Alan J., Önnerfjord, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185927/
https://www.ncbi.nlm.nih.gov/pubmed/35689293
http://dx.doi.org/10.1186/s13075-022-02828-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185927/
https://www.ncbi.nlm.nih.gov/pubmed/35689293
http://dx.doi.org/10.1186/s13075-022-02828-4

Ejemplares similares